Nucleus Pulposus Cell Reprogramming With Master Transcription Factors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating intervertebral disc degeneration, such as transplanting nucleus pulposus cells or stem cells, face challenges in reproducibility, cost, and the inability to maintain the active nucleus pulposus cell phenotype post-transplantation, with limited effectiveness of existing transcription factors like SOX9 for inducing a specific nucleus pulposus cell phenotype.
Innovation Solution
The use of a combination of transcription factors, including Brachyury (T), SRY-box6 (SOX6), and Forkhead Box Q1 (FOXQ1), along with other factors, to induce an active nucleus pulposus cell phenotype from terminally differentiated cells or stem cells, enabling direct reprogramming and maintaining the phenotype under severe microenvironment conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods transplant nucleus pulposus cells or stem cells, then treatment is provided, but the active nucleus pulposus cell phenotype cannot be maintained post-transplantation and reproducibility is poor
Solution Approach 1:
The invention changes the biochemical parameters of the culture system by introducing specific transcription factors (SOX9, T, SOX6, FOXQ1, PITX1, PAX1) to induce nucleus pulposus cell phenotype. This parameter change enables reliable phenotype maintenance post-transplantation by directly activating the molecular program required for nucleus pulposus cell differentiation and function.
Solution Approach 2:
The invention uses transcription factors as intermediary molecules to mediate the differentiation process. These transcription factors act as mediators that translate the transplantation procedure into specific cellular phenotypic outcomes, ensuring that transplanted cells adopt and maintain the active nucleus pulposus cell phenotype through controlled gene expression.
2Reliability
If existing transcription factors like SOX9 are used to induce nucleus pulposus cell phenotype, then some differentiation is achieved, but the specific active nucleus pulposus cell phenotype is not fully induced and effectiveness is limited
Solution Approach 1:
The invention merges multiple transcription factors (SOX9, T, SOX6, FOXQ1, PITX1, PAX1) into a combined differentiation induction system. This combination approach synergistically activates the complete molecular program for nucleus pulposus cell phenotype, achieving reliable induction of the specific active phenotype that single factors cannot accomplish alone.
Solution Approach 2:
The invention creates a composite transcription factor system where multiple factors work together as a unified differentiation induction mechanism. This composite approach integrates the functions of individual transcription factors to produce the specific active nucleus pulposus cell phenotype with high reliability and reproducibility.
3Reliability
If donor nucleus pulposus cells are obtained through surgery, then cell transplantation is possible, but donor cells are often damaged due to diseases, trauma, or aging and lack sufficient effectiveness
Solution Approach 1:
The invention enables cells to self-differentiate into the active nucleus pulposus cell phenotype through transcription factor induction. This self-service mechanism allows any nucleated cell to transform into functional nucleus pulposus cells without requiring pre-existing healthy donor cells, thereby ensuring high effectiveness of transplanted cells regardless of donor condition.
Solution Approach 2:
The invention changes the cellular state parameters by introducing transcription factors that reprogram nucleated cells into active nucleus pulposus cells. This parameter change transforms potentially damaged or aged donor cells into healthy, functional nucleus pulposus cells, overcoming the limitations of donor cell quality and availability.
4Productivity
If stem cells are cultured to amplify nucleus pulposus cells, then cell supply is increased, but the traits of nucleus pulposus cells are lost through dedifferentiation
Solution Approach 1:
The invention maintains continuous expression of nucleus pulposus cell-specific transcription factors during cell culture and amplification. This continuous molecular action ensures that cell traits are preserved throughout the amplification process, preventing dedifferentiation while enabling productive cell expansion for transplantation.
Solution Approach 2:
The invention implements a feedback mechanism where transcription factor expression is maintained or enhanced during culture to prevent trait loss. This feedback control ensures that as cells are amplified, they continuously receive the molecular signals necessary to maintain their nucleus pulposus cell phenotype, thereby preserving cell traits throughout the productivity-enhancing culture process.
Data Source
AI summary
Provided is reproducible means that enables the production of an active nucleus pulposus cell phenotype from desired cells such as terminally differentiated cells or pluripotent or multipotent stem cells. Provided is a differentiation inducer containing an effective amount of a gene of at least two transcription factors selected from the group consisting of Brachyury (T), SRY-box6 (SOX6), and Forkhead Box Q1 (FOXQ1), or homologs thereof (nucleus pulposus cell master regulator transcription factor), or a product thereof.